Every finding on this page is sourced directly from the Office of the Auditor General of Manitoba, the College of Pharmacists of Manitoba, and federal health surveillance data. Medisyns does not manufacture the problem — it is documented in official records.
Source integrity policy: Every statistic on this page is cited with its primary source URL. We do not use secondary sources, industry estimates, or aggregator sites. If a number cannot be traced to a government document, auditor report, or peer-reviewed study, it does not appear here. Sources are dated — where data is from an earlier audit, this is noted explicitly.
In its audit of Manitoba's Pharmacare program, the Auditor General of Manitoba found that Manitoba Health did not monitor physician prescribing practices, nor did it actively promote appropriate prescribing through best-practice information. The audit identified 101 cases in 2003 in which individuals received a narcotic or controlled drug and used four to six physicians and four to six pharmacies to obtain drugs — a textbook multi-pharmacy shopping pattern that Medisyns is designed to detect and flag in real time. The Auditor General concluded that Manitoba Health had "limited means to attempt to control program costs through influencing physicians' prescribing practices."
In a 2018 forensic audit, the Auditor General of Manitoba found that a former Manitoba Pharmacare employee processed over $236,000 in suspicious payments between 2007 and 2015 through manual adjustments in the DPIN billing system. The fraud was enabled by an internal control environment with "many significant gaps," including no supervision, weak or absent supporting documentation, and few automated controls. The Auditor General made five recommendations. In the most recent follow-up, conducted in 2022, only one of the five had been implemented. As of the March 2025 Public Accounts Committee, the department acknowledged that technology limitations and reliance on manual claims processing had not been fully addressed.
In May and June 2024, the College of Pharmacists of Manitoba issued active forgery alerts to all registrants. Prescription forgeries for Percocet (oxycodone) and Cotridin (codeine/pseudoephedrine) are the most commonly reported, often for large quantities — typically 120 tablets of Percocet or 210 ml of Cotridin. Forgeries are increasingly transmitted by fax from out-of-province area codes, allowing rapid distribution to multiple pharmacies simultaneously. The College confirmed that forgery attempts are not limited to Winnipeg — pharmacies throughout Manitoba have been affected. A wide range of Manitoba and out-of-province prescribers have been impersonated.
Manitoba recorded 382 apparent opioid toxicity deaths in 2023, a decrease of 2.9% from 2022 but representing the second-highest total since national tracking began. The Drug Programs Information Network (DPIN) — Manitoba's provincial pharmacy billing and dispensing system — performs drug utilization review checks at the point of dispensing, but the system only shows a patient's most recent six months of medication history. This limitation, first identified by the Auditor General in 2006 and confirmed in current Manitoba Health documentation, means that longer-term multi-pharmacy shopping patterns are structurally invisible to the system without a dedicated cross-system verification layer.
Data currency note: The primary Pharmacare performance audit (Finding 1) was published by the Auditor General of Manitoba in April 2006 and covers fiscal year 2003/04. No subsequent performance audit of Manitoba's prescription drug monitoring or pharmacy dispensing practices has been published by the OAG. The 2018 forensic audit (Finding 2) and the 2024 College of Pharmacists alerts (Finding 3) are recent. The 2006 Auditor General finding on multi-pharmacy shopping is presented as audited historical evidence of a structural gap, not as a claim that exactly 101 cases exist today — the current number is unknown precisely because the monitoring gap persists.
The Auditor General of Manitoba confirmed in 2006 that individuals were obtaining narcotics from up to six physicians and six pharmacies simultaneously — and that Manitoba Health had no mechanism to detect or intervene. DPIN has since added real-time billing adjudication, but its 6-month rolling window and billing-system design do not constitute a fraud-prevention verification layer. The 2018 forensic audit confirmed that DPIN's manual claims process remained exploitable by insiders for nearly a decade before detection. Medisyns operates at the verification layer — every fill cross-checked against prescriber registry, multi-pharmacy history beyond 6 months, insurer eligibility, and cross-party duplication — before the drug is dispensed.
The 101 cases the Auditor General identified in 2003 required individuals using 4–6 pharmacies. Medisyns closes this gap with a cross-system check on every fill, regardless of which pharmacy processes it.
Faxed forgeries succeed partly because pharmacies cannot instantly verify prescriber identity against a real-time registry. Medisyns verification fires before the drug is dispensed.
DPIN's rolling 6-month history is a structural constraint, not a policy choice. Medisyns maintains a verifiable cross-system record of every fill event — timestamped and auditable.
Medisyns is in active conversations with provincial health systems. If you work in or with provincial health policy, procurement, or health IT — we'd like to talk.